Navigation Links
San Diego Zoo researchers contribute to project using mummy DNA to differentiate croc species
Date:12/19/2011

The Nile crocodile is a species that was identified by ancient Egyptians. Genetic analysis done by a group of geneticists using samples taken from species throughout the animal's range and including DNA from mummified crocodile remains indicates that more than one species is known by this name.

"This paper provides a remarkable surprise: the Nile crocodile is not a single species, as previously thought, but instead demonstrates two species - living side-by side - constitute what has been called the Nile croc." Said Marlys Houck, geneticist with San Diego Zoo Global's Institute of Conservation Research. "Even more remarkably, they are not each other's closest relatives; one is more closely related to New World crocodilians. The cryptic Crocodylus suchus is a unique entity worthy of a conservation strategy separate from the Nile crocodile populations of East and southern Africa."

The study, published in the October issue of Molecular Ecology, provides important information about a species that is not only an important historical icon but also critically endangered. Recent survey efforts indicate that Crocodylus suchus is declining or extirpated throughout much of its distribution. Conservationists feel that without proper recognition of this species, current sustainable use-based management policies for the Nile crocodile may do more harm than good.


'/>"/>

Contact: Christina Simmons
csimmons@sandiegozoo.org
619-685-3291
Zoological Society of San Diego
Source:Eurekalert

Page: 1

Related biology news :

1. NIH doles out $3M in new innovator awards to 2 UC San Diego faculty
2. UC San Diego bioengineers fill holes in science of cellular self-organization
3. San Diego Supercomputer Center and UCSD announce Triton Resource
4. Field-hospital-on-a-chip project awarded to nanoengineer from UC San Diego
5. UC San Diego researchers use metagene portraits to reveal distinct stages of kidney formation
6. UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology
7. UC San Diego senior named Churchill Scholar for extraordinary undergraduate research
8. UC San Diego bioengineering professor trey ideker wins 2009 Overton Prize
9. New method developed by UC San Diego bioengineers gives regenerative medicine a boost
10. Regional partnership to develop algal biofuels gets backing of San Diego leaders
11. UC San Diegos $3 million NSF grant to fund science festivals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ), a ... live webcast of its Annual Meeting of Shareholders on Tuesday, January ... can be accessed from the BD corporate website at http://www.bd.com/investors/ ... ... BD is a global medical technology company that is ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Clinical Ops Executives 2017 in its continued commitment to the advancement of the ... to discuss current issues related to clinical trial planning and management. , ...
Breaking Biology Technology: